METTL3‐mediated m6A modification of pri‐miR‐148a‐3p affects prostate cancer progression by regulating TXNIP
暂无分享,去创建一个
[1] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[2] S. Zappavigna,et al. A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells , 2022, International journal of molecular sciences.
[3] A. Rouhi,et al. miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cells , 2022, Blood advances.
[4] E. Rakha,et al. The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer , 2022, Cancers.
[5] Fumihiko Urabe,et al. miRNAs in prostate cancer: Intercellular and extracellular communications , 2022, International journal of urology : official journal of the Japanese Urological Association.
[6] S. Mashele,et al. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches , 2022, Molecules.
[7] Mahasin Abdel Rhman,et al. Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword? , 2022, European journal of pharmacology.
[8] Wei Wei,et al. Paeoniflorin-6'O-benzene sulfonate suppresses fibroblast-like synoviocytes proliferation and migration in rheumatoid arthritis through regulating GRK2-Gβγ interaction. , 2022, Experimental and therapeutic medicine.
[9] Minglong Shao,et al. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research , 2022, Frontiers in Pharmacology.
[10] Y. Zhu,et al. METTL3 promotes prostate cancer progression by regulating miR‐182 maturation in m6A‐dependent manner , 2022, Andrologia.
[11] Alhaji Osman Smith,et al. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors , 2022, Frontiers in Immunology.
[12] Huan Xu,et al. METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling , 2022, Cell transplantation.
[13] L. Zuo,et al. Function of N6-Methyladenosine Modification in Tumors , 2021, Journal of oncology.
[14] E. Konac,et al. miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression , 2021, Oncology letters.
[15] Jianquan Hou,et al. METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d , 2021, Aging.
[16] H. Masutani. Thioredoxin-Interacting Protein in Cancer and Diabetes , 2021, Antioxidants & redox signaling.
[17] Yabing Chen,et al. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells , 2021, Theranostics.
[18] D. Ribatti,et al. microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis , 2020, Frontiers in Oncology.
[19] Wei Wang,et al. Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer , 2020, Cell biology international.
[20] Dong Li,et al. MiR-135a-5p inhibits vascular smooth muscle cells proliferation and migration by inactivating FOXO1 and JAK2 signaling pathway. , 2020, Pathology, research and practice.
[21] E. Li,et al. METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma. , 2020, American journal of cancer research.
[22] Yun Wang,et al. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway , 2020, Frontiers in Oncology.
[23] Ying Luo,et al. miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer , 2019, Journal of breast cancer.
[24] Shao-Gang Ma,et al. Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway , 2019, Cell proliferation.
[25] Yan Li,et al. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia. , 2019, Molecular medicine reports.
[26] Danyang Yu,et al. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition. , 2018, Gynecologic oncology.
[27] T. Du,et al. Long non‐coding RNA CCAT1/miR‐148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization , 2018, The Prostate.
[28] H. Guan,et al. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. , 2018, Thyroid : official journal of the American Thyroid Association.
[29] R. DePinho,et al. Genetics and biology of prostate cancer , 2018, Genes & development.
[30] J. Halgunset,et al. Increased levels of serum miR‐148a‐3p are associated with prostate cancer , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[31] P. Manavella,et al. miRNA Biogenesis: A Dynamic Pathway. , 2016, Trends in plant science.
[32] Gang Zhang,et al. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway , 2016, Oncotarget.
[33] H. Abrahamse,et al. The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. , 2016, Journal of photochemistry and photobiology. B, Biology.
[34] D. Stewart,et al. Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease , 2015, PloS one.
[35] S. Tavazoie,et al. N6-methyladenosine marks primary microRNAs for processing , 2015, Nature.
[36] Hailong Xie,et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. , 2014, Biochemical and biophysical research communications.
[37] Y. Homma,et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression , 2010, Prostate Cancer and Prostatic Diseases.
[38] Muneesh Tewari,et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.
[39] Ryan M. O’Connell,et al. Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.
[40] Shan Jiang,et al. Silencing of DJ-1 reduces proliferation, invasion, and migration of papillary thyroid cancer cells in vitro, probably by increase of PTEN expression. , 2019, International journal of clinical and experimental pathology.
[41] A. Jemal,et al. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. , 2019, European urology.